YPF Sociedad Anonima Common Stock (YPF)
35.95
-0.21 (-0.58%)
NYSE · Last Trade: Jan 2nd, 11:59 AM EST
As the sun rises over the Neuquén Basin on January 2, 2026, the landscape of global energy has shifted. Just yesterday, the Argentine government officially lifted the final vestiges of its long-standing currency controls, known as the "cepo," marking a watershed moment for foreign investors. At the center of this
Via MarketMinute · January 2, 2026
YPF stock shows strong technical momentum and a high-quality breakout setup, offering a clear trade plan for technical investors.
Via Chartmill · December 25, 2025
One investor just made a big bet on ProPetro’s evolution—here’s what they may be seeing that the market hasn't completely priced in.
Via The Motley Fool · December 3, 2025
One institutional buyer just made a notable bet on Vista’s rebound—but the details may matter even more than the trade.
Via The Motley Fool · December 3, 2025
Core Scientific is reinventing itself—fast—and one major investor just made a bold bet on where that pivot leads.
Via The Motley Fool · December 3, 2025
YPF stock shows strong technical uptrend and high-quality consolidation pattern, signaling a potential breakout setup for traders.
Via Chartmill · December 1, 2025
Top weekly large-cap gainers included Teradyne, Wayfair, Illumina, Guardant Health, ASE, C.H. Robinson, Lumen, Symbotic, Credo, YPF after strong results.
Via Benzinga · November 2, 2025
Buenos Aires, Argentina – October 27, 2025 – Argentine financial markets have erupted in a massive rally, with local stocks and the peso surging, following a resounding victory for President Javier Milei's party, La Libertad Avanza (LLA), in the October 2025 midterm legislative elections. This electoral triumph, which saw LLA secure a
Via MarketMinute · October 27, 2025
Shares of Argentine stocks across various industries are rising Monday following results from a key midterm election in the Latin American country.
Via Benzinga · October 27, 2025
Shares of YPF, the state-owned oil firm, jumped 24% while Banco BBVA Argentina’s U.S. depository shares soared 35%. The Global X MSCI Argentina ETF also rose above 17%.
Via Stocktwits · October 27, 2025
Via Benzinga · October 12, 2025
Eni and YPF signed a key technical step toward FID on Argentina's LNG project, while Eni shares slipped.
Via Benzinga · October 10, 2025
Discover 3 oil & gas stocks—KNOP, REPX, YPF—rising in value rankings this week, signaling strong undervaluation and buy potential.
Via Benzinga · October 6, 2025
Via Benzinga · September 8, 2025
Discover 3 undervalued oil & gas stocks joining the top 10% in value ranking. Don't miss Crescent Energy, Plains All American, and YPF.
Via Benzinga · September 3, 2025
YPF stock meets key CAN SLIM criteria with strong earnings growth, high relative strength, and solid fundamentals, making it a potential high-momentum pick.
Via Chartmill · August 7, 2025
YPF (NYSE:YPF) meets key CANSLIM criteria with strong earnings growth, high relative strength, and solid fundamentals, making it a stock to watch for growth investors.
Via Chartmill · July 16, 2025
YPF (NYSE:YPF) meets key CANSLIM criteria with strong earnings growth, high relative strength, and manageable debt. A potential candidate for growth investors.
Via Chartmill · June 24, 2025
YPF (NYSE:YPF) meets key CANSLIM criteria with strong earnings growth, high relative strength, and improving fundamentals, making it a candidate for growth investors.
Via Chartmill · June 2, 2025
A fundamental analysis of (NYSE:YPF): Is YPF S.A.-SPONSORED ADR (NYSE:YPF) suited for growth investing?
Via Chartmill · May 12, 2025
Via Benzinga · May 4, 2025
Argentina's lifting of currency controls has boosted investor confidence, as reflected in ARGT's 3.5% jump, outperforming leading indices like EEM and SPY.
Via Benzinga · April 28, 2025
A fundamental analysis of (NYSE:YPF): Delving into YPF S.A.-SPONSORED ADR (NYSE:YPF)'s Growth Prospects.
Via Chartmill · April 21, 2025
Top performers last week: ServiceTitan, Summit Therapeutics, YPF, Eli Lilly, MicroStrategy, America Movil, Ericsson, Insmed, Diamondback, Neurocrine Biosciences.
Via Benzinga · April 20, 2025